Avalon Globocare Corp Financials
This page shows Avalon Globocare Corp (ALBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Avalon Globocare Corp has an operating margin of -369.6%, meaning the company retains $-370 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -1165.6% the prior year.
Avalon Globocare Corp's revenue declined 1.3% year-over-year, from $1.4M to $1.3M. This contraction results in a growth score of 25/100.
Avalon Globocare Corp has a moderate D/E ratio of 1.95. This balance of debt and equity financing earns a leverage score of 39/100.
Avalon Globocare Corp's current ratio of 0.23 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.
Avalon Globocare Corp passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Avalon Globocare Corp generates $0.63 in operating cash flow (-$5.0M OCF vs -$7.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Avalon Globocare Corp earns $-116.1 in operating income for every $1 of interest expense (-$4.9M vs $42K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Avalon Globocare Corp generated $1.3M in revenue in fiscal year 2024. This represents a decrease of 1.3% from the prior year.
Avalon Globocare Corp's EBITDA was -$4.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 72.7% from the prior year.
Avalon Globocare Corp reported -$7.9M in net income in fiscal year 2024. This represents an increase of 52.7% from the prior year.
Avalon Globocare Corp earned $-8.44 per diluted share (EPS) in fiscal year 2024. This represents an increase of 64.5% from the prior year.
Avalon Globocare Corp held $2.9M in cash against $0 in long-term debt as of fiscal year 2024.
Avalon Globocare Corp had 1M shares outstanding in fiscal year 2024. This represents an increase of 96.7% from the prior year.
Avalon Globocare Corp's operating margin was -369.6% in fiscal year 2024, reflecting core business profitability. This is up 796.1 percentage points from the prior year.
Avalon Globocare Corp's net profit margin was -592.7% in fiscal year 2024, showing the share of revenue converted to profit. This is up 643.5 percentage points from the prior year.
Avalon Globocare Corp invested $0 in research and development in fiscal year 2024. This represents a decrease of 100.0% from the prior year.
ALBT Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $350K-0.1% | $350K+0.2% | $350K+147.5% | $141K-56.9% | $328K-36.8% | $519K+15.5% | $449K+2.4% | $439K |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$76K+98.0% | -$3.9M-115.2% | -$1.8M-37.9% | -$1.3M+12.9% | -$1.5M-78.4% | -$843K+91.4% | -$9.8M-758.0% | -$1.1M |
| Interest Expense | $267K-74.7% | $1.1M+88.9% | $560K+142.3% | -$1.3M-263.8% | $808K+7524.2% | $11K+101.6% | -$654K-248.9% | $439K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$254K+98.1% | -$13.5M-442.2% | -$2.5M+8.9% | -$2.7M-27.8% | -$2.1M-55.9% | -$1.4M+85.7% | -$9.6M-543.4% | -$1.5M |
| EPS (Diluted) | $-0.06+99.0% | $-6.22-335.0% | $-1.43+25.1% | $-1.91 | $-2.85-53.2% | $-1.86 | $-21.18 | $-2.06 |
ALBT Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.1M+14.3% | $8.0M-24.7% | $10.6M-49.4% | $21.0M+7.5% | $19.5M-4.0% | $20.3M-1.2% | $20.6M-31.3% | $30.0M |
| Current Assets | $2.1M+123.9% | $933K-66.6% | $2.8M-13.7% | $3.2M+354.0% | $713K-8.3% | $778K-8.6% | $851K-1.5% | $864K |
| Cash & Equivalents | $334K+65.7% | $202K-85.3% | $1.4M-52.1% | $2.9M+1324.1% | $201K-34.3% | $305K+7.0% | $285K-16.5% | $342K |
| Inventory | $80K-7.4% | $86K-4.1% | $90K-2.3% | $92K | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $13.6M-9.8% | $15.1M+4.1% | $14.5M+4.5% | $13.9M-8.1% | $15.1M+5.7% | $14.3M+8.1% | $13.2M+0.5% | $13.1M |
| Current Liabilities | $13.6M-9.7% | $15.1M+4.3% | $14.4M+4.1% | $13.9M+61.6% | $8.6M+10.1% | $7.8M+15.4% | $6.8M+1.1% | $6.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$4.5M+36.8% | -$7.1M-82.8% | -$3.9M-154.8% | $7.1M+60.8% | $4.4M-27.0% | $6.1M-17.8% | $7.4M-56.2% | $16.8M |
| Retained Earnings | -$103.9M-0.2% | -$103.6M-14.9% | -$90.2M-2.8% | -$87.7M-5.3% | -$83.3M-2.6% | -$81.1M-1.7% | -$79.8M-13.6% | -$70.2M |
ALBT Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.4M-11.0% | -$1.2M+32.0% | -$1.8M-67.1% | -$1.1M+0.3% | -$1.1M-18.1% | -$916K-15.0% | -$796K+41.0% | -$1.3M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | -$12+60.0% | -$30 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | -$796K+41.0% | -$1.3M |
| Investing Cash Flow | $658K | $0-100.0% | $95K | $0 | N/A | N/A | $12-60.0% | $30 |
| Financing Cash Flow | $835K+1348.5% | $58K-73.8% | $220K-92.4% | $2.9M+171.2% | $1.1M+14.6% | $937K+27.6% | $734K-29.7% | $1.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ALBT Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -21.8%+1087.8pp | -1109.6%-593.1pp | -516.5%+410.5pp | -927.0%-468.2pp | -458.8%-296.4pp | -162.4%+2016.3pp | -2178.8%-1918.8pp | -259.9% |
| Net Margin | -72.6%+3768.2pp | -3840.9%-3131.3pp | -709.6%+1218.0pp | -1927.6%-1277.4pp | -650.2%-386.7pp | -263.5%+1862.8pp | -2126.3%-1788.0pp | -338.3% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -2.8%+165.7pp | -168.5%-145.1pp | -23.4%-10.4pp | -13.0%-2.1pp | -10.9%-4.2pp | -6.7%+39.7pp | -46.4%-41.5pp | -5.0% |
| Current Ratio | 0.15+0.1 | 0.06-0.1 | 0.19-0.0 | 0.23+0.2 | 0.08-0.0 | 0.10-0.0 | 0.130.0 | 0.13 |
| Debt-to-Equity | -3.03-0.9 | -2.12+1.6 | -3.73-5.7 | 1.95-1.5 | 3.42+1.1 | 2.36+0.6 | 1.79+1.0 | 0.78 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | -177.2%+130.0pp | -307.2% |
Note: The current ratio is below 1.0 (0.23), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Avalon Globocare Corp's annual revenue?
Avalon Globocare Corp (ALBT) reported $1.3M in total revenue for fiscal year 2024. This represents a -1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Avalon Globocare Corp's revenue growing?
Avalon Globocare Corp (ALBT) revenue declined by 1.3% year-over-year, from $1.4M to $1.3M in fiscal year 2024.
Is Avalon Globocare Corp profitable?
No, Avalon Globocare Corp (ALBT) reported a net income of -$7.9M in fiscal year 2024, with a net profit margin of -592.7%.
What is Avalon Globocare Corp's earnings per share (EPS)?
Avalon Globocare Corp (ALBT) reported diluted earnings per share of $-8.44 for fiscal year 2024. This represents a 64.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Avalon Globocare Corp's EBITDA?
Avalon Globocare Corp (ALBT) had EBITDA of -$4.1M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Avalon Globocare Corp's operating margin?
Avalon Globocare Corp (ALBT) had an operating margin of -369.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Avalon Globocare Corp's net profit margin?
Avalon Globocare Corp (ALBT) had a net profit margin of -592.7% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Avalon Globocare Corp's operating cash flow?
Avalon Globocare Corp (ALBT) generated -$5.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Avalon Globocare Corp's total assets?
Avalon Globocare Corp (ALBT) had $21.0M in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Avalon Globocare Corp have outstanding?
Avalon Globocare Corp (ALBT) had 1M shares outstanding as of fiscal year 2024.
What is Avalon Globocare Corp's current ratio?
Avalon Globocare Corp (ALBT) had a current ratio of 0.23 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Avalon Globocare Corp's debt-to-equity ratio?
Avalon Globocare Corp (ALBT) had a debt-to-equity ratio of 1.95 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Avalon Globocare Corp's return on assets (ROA)?
Avalon Globocare Corp (ALBT) had a return on assets of -37.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Avalon Globocare Corp's cash runway?
Based on fiscal year 2024 data, Avalon Globocare Corp (ALBT) had $2.9M in cash against an annual operating cash burn of $5.0M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Avalon Globocare Corp's Piotroski F-Score?
Avalon Globocare Corp (ALBT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Avalon Globocare Corp's earnings high quality?
Avalon Globocare Corp (ALBT) has an earnings quality ratio of 0.63x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Avalon Globocare Corp cover its interest payments?
Avalon Globocare Corp (ALBT) has an interest coverage ratio of -116.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Avalon Globocare Corp?
Avalon Globocare Corp (ALBT) scores 16 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.